Atul approves ₹167 cr capex for MCPP-p and MCPA capacity addition
Atul Limited's board approved a ₹167 crore investment to create new manufacturing units for MCPP-p (1,000 TPA) and MCPA (750 TPA). The project, funded via internal accruals, aims to enhance the company's phenoxy herbicide offerings and will be completed within 67 weeks.
*this image is generated using AI for illustrative purposes only.
Atul Limited’s board of directors has approved a capital expenditure of ₹167 crore to establish new manufacturing facilities for Mecoprop-p (MCPP-p) and 2-methyl-4-chlorophenoxyacetic acid (MCPA). The expansion, aimed at strengthening the company’s position in phenoxy herbicides, will add a combined annual production capacity of 1,750 tonnes, fully funded through internal accruals.
The investment is structured to be completed within 67 weeks, with no existing capacity currently utilized for these specific products. This move aligns with Atul’s strategy to produce value-added downstream products derived from o-Cresol and MCA, thereby diversifying its specialty chemicals portfolio.
Project Specifications
The board meeting held on July 24, 2026, from 10:15 am to 02:15 pm, formalized the details of the capital expenditure proposal. The project involves greenfield capacity additions for two key agrochemical intermediates.
| Parameter | Details |
|---|---|
| Total Investment | ₹167 crore |
| Exclusions | Working capital and GST |
| MCPP-p Capacity | 1,000 tonnes per annum (TPA) |
| MCPA Capacity | 750 tonnes per annum (TPA) |
| Implementation Timeline | 67 weeks |
| Financing Mode | Internal accruals |
| Existing Capacity | Nil |
Strategic Rationale
The primary objective of this capital expenditure is to expand Atul’s portfolio in the phenoxy herbicides segment. By producing MCPP-p and MCPA, the company aims to leverage its existing infrastructure for o-Cresol and MCA to create higher-margin downstream products. The decision to fund the project entirely through internal accruals indicates strong cash flow generation capabilities, reducing reliance on external debt for this expansion.
What the Numbers Show
The approval of a ₹167 crore project with a relatively short implementation period of 67 weeks suggests a focused execution plan. With zero existing capacity in these specific segments, the entire output represents incremental growth. The reliance on internal accruals for funding further underscores management’s confidence in the company’s financial health and its ability to self-fund strategic expansions without diluting equity or increasing leverage.
Historical Stock Returns for Atul
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +4.53% | +4.80% | -1.53% | +9.97% | -4.30% | -30.76% |
How will the addition of 1,750 tonnes of phenoxy herbicide capacity impact Atul's overall revenue mix and gross margins over the next two fiscal years?
Given the 67-week implementation timeline, what are the key regulatory or supply chain risks that could delay the commissioning of these greenfield facilities?
Will Atul pursue backward integration to secure raw material supplies for MCPP-p and MCPA, or will it continue relying on external procurement for o-Cresol and MCA derivatives?
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
